Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Research Article

Prevalence of Toxoplasma gondii and Toxocara canis Among Myositis Patients in the Southwest of Iran

Author(s): Jasem Saki*, Karim Mowla, Reza Arjmand, Forough Kazemi and Somayeh Fallahizadeh

Volume 21, Issue 1, 2021

Published on: 31 December, 2019

Page: [43 - 48] Pages: 6

DOI: 10.2174/1871526520666191231123159

Price: $65

Abstract

Introduction: Parasitic myositis is caused by some parasites, such as Toxoplasma gondii) T. gondii (and Toxocara canis (T. canis). So, the aim of the study was to evaluate the prevalence T. gondii and T. canis in patients with myositis and healthy individuals.

Methods: A total of 108 samples were randomly selected as the control (54 healthy individuals) and test (54 myositis patients) groups. IgG and IgM antibodies (Ab) against T. gondii and IgG Ab against T. canis were measured by the enzyme-linked immunosorbent assay (ELISA). The detection of chronic and acute toxoplasmosis was performed by the ELISA IgG avidity. The presence of T. gondii in the blood was evaluated using the nested polymerase chain reaction (nested-PCR).

Results: Of 108, 33 (30.6%) cases were positive for IgG against T. gondii that 19 (35.2%) and 14 (25.9%) were observed in myositis patients and healthy individuals, respectively (P=0.296). Of 19 positive cases, 12 (63.2%) and 7 (36.8%) cases were detected as chronic and acute toxoplasmosis, respectively, while, all positive cases in the control group had chronic toxoplasmosis (P=0.013). One (1.9%) sample was positive for anti- T. gondii IgM and two (3.7%) samples were positive for IgG against T. canis by the ELISA that these positive cases were observed only in myositis patients (P=1.000 P=0.495, respectively). B1 T. gondii gene was amplified in 12 (63.2%) and 1 (7.1%) in myositis patients and healthy subjects (P=0.001).

Conclusion: Our findings showed that there was a relatively high prevalence of acute toxoplasmosis in myositis patients in comparison with the control subjects in the Southwest of Iran.

Keywords: Toxoplasma gondii, Toxocara canis, Myositis, ELISA, Nested-PCR, chronic toxoplasmosis.

Graphical Abstract
[1]
El-Beshbishi, S.N.; Ahmed, N.N.; Mostafa, S.H.; El-Ganainy, G.A. Parasitic infections and myositis. Parasitol. Res., 2012, 110(1), 1-18.
[http://dx.doi.org/10.1007/s00436-011-2609-8] [PMID: 21881948]
[2]
Infectious myositis and related syndromes. Seminars in Arthritis and Rheumatism, 1982, 11(4), pp. 421-439.
[3]
Crum, N.F. Bacterial pyomyositis in the United States. Am. J. Med., 2004, 117(6), 420-428.
[http://dx.doi.org/10.1016/j.amjmed.2004.03.031] [PMID: 15380499]
[4]
Bennett, JE; Dolin, R Blaser, MJ Principles and Practice of Infectious Diseases E-Book: Elsevier Health Science, 2014.
[5]
Gherardi, R.; Baudrimont, M.; Lionnet, F.; Salord, J.M.; Duvivier, C.; Michon, C.; Wolff, M.; Marche, C. Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study. Ann. Neurol., 1992, 32(4), 535-542.
[http://dx.doi.org/10.1002/ana.410320409] [PMID: 1456737]
[6]
Torrey, E.F.; Bartko, J.J.; Yolken, R.H. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull., 2012, 38(3), 642-647.
[http://dx.doi.org/10.1093/schbul/sbs043] [PMID: 22446566]
[7]
Wohlfert, E.A.; Blader, I.J.; Wilson, E.H. Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle. Trends Parasitol., 2017, 33(7), 519-531.
[http://dx.doi.org/10.1016/j.pt.2017.04.001] [PMID: 28483381]
[8]
Macuhova, K.; Kumagai, T.; Akao, N.; Ohta, N. Loop-mediated isothermal amplification assay for detection and discrimination of Toxocara canis and Toxocara cati eggs directly from sand samples. J. Parasitol., 2010, 96(6), 1224-1227.
[http://dx.doi.org/10.1645/GE-2394.1] [PMID: 21158640]
[9]
Azian, M.Y.; Sakhone, L.; Hakim, S.L.; Yusri, M.Y.; Nurulsyamzawaty, Y.; Zuhaizam, A.H.; Rodi, I.M.; Maslawaty, M.N. Detection of helminth infections in dogs and soil contamination in rural and urban areas. Southeast Asian J. Trop. Med. Public Health, 2008, 39(2), 205-212.
[PMID: 18564703]
[10]
Ozlati, M.; Spotin, A.; Shahbazi, A.; Mahami-Oskouei, M.; Hazratian, T.; Adibpor, M.; Ahmadpour, E.; Dolatkhah, A.; Khoshakhlagh, P. Genetic variability and discrimination of low doses of Toxocara spp. from public areas soil inferred by loop-mediated isothermal amplification assay as a field-friendly molecular tool. Vet. World, 2016, 9(12), 1471-1477.
[http://dx.doi.org/10.14202/vetworld.2016.1471-1477] [PMID: 28096624]
[11]
Walsh, S.S.; Robson, W.J.; Hart, C.A. Acute transient myositis due to Toxocara. Arch. Dis. Child., 1988, 63(9), 1087-1088.
[http://dx.doi.org/10.1136/adc.63.9.1087] [PMID: 3178271]
[12]
Betteridge, Z.; McHugh, N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J. Intern. Med., 2016, 280(1), 8-23.
[http://dx.doi.org/10.1111/joim.12451] [PMID: 26602539]
[13]
Kazemi, F.; Fallahizadeh, S.; Feizhadad, M.H. Seroepidemiological study of toxoplasmosis in hemodialysis patients of Ahvaz, Southwest of Iran. Int. J. Biomed.Public Health., 2018, 1(1), 12-16.
[http://dx.doi.org/10.22631/ijbmph.2018.55340]
[14]
Fallahi, Sh.; Kazemi, B. Seyyed tabaei, S.J.; Bandehpour, M.; Lasjerdi, Z.; Taghipour, N.; Zebardast, N.; Nikmanesh, B.; Omrani, V.F.; Ebrahimzadeh, F. Comparison of the RE and B1 gene for detection of Toxoplasma gondii infection in children with cancer. Parasitol. Int., 2014, 63(1), 37-41.
[http://dx.doi.org/10.1016/j.parint.2013.08.005] [PMID: 23993996]
[15]
Inan, M.; Sakru, N.; Vatansever, U.; Bilgi, S. Visceral larva migrans presenting as acute abdomen in a child. J. Pediatr. Surg., 2006, 41(3), e7-e9.
[http://dx.doi.org/10.1016/j.jpedsurg.2005.11.081] [PMID: 16516616]
[16]
Plonquet, A.; Bassez, G.; Authier, F.J.; Dray, J.M.; Farcet, J.P.; Gherardi, R.K. Toxoplasmic myositis as a presenting manifestation of idiopathic CD4 lymphocytopenia. Muscle Nerve, 2003, 27(6), 761-765.
[http://dx.doi.org/10.1002/mus.10376] [PMID: 12766990]
[17]
Harland, C.C.; Marsden, J.R.; Vernon, S.A.; Allen, B.R. Dermatomyositis responding to treatment of associated toxoplasmosis. Br. J. Dermatol., 1991, 125(1), 76-78.
[http://dx.doi.org/10.1111/j.1365-2133.1991.tb06046.x] [PMID: 1873210]
[18]
Cuturic, M.; Hayat, G.R.; Vogler, C.A.; Velasques, A. Toxoplasmic polymyositis revisited: case report and review of literature. Neuromuscul. Disord., 1997, 7(6-7), 390-396.
[http://dx.doi.org/10.1016/S0960-8966(97)00098-9] [PMID: 9327404]
[19]
Cuomo, G.; D’Abrosca, V.; Rizzo, V.; Nardiello, S.; La Montagna, G.; Gaeta, G.B.; Valentini, G. Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature. Infection, 2013, 41(4), 859-862.
[http://dx.doi.org/10.1007/s15010-013-0427-x] [PMID: 23543435]
[20]
Hassene, A.; Vital, A.; Anghel, A.; Guez, S.; Series, C. Acute acquired toxoplasmosis presenting as polymyositis and chorioretinitis in immunocompetent patient. Joint Bone Spine, 2008, 75(5), 603-605.
[http://dx.doi.org/10.1016/j.jbspin.2007.08.009] [PMID: 18406191]
[21]
Montoya, J.G.; Liesenfeld, O.; Kinney, S.; Press, C.; Remington, J.S. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol., 2002, 40(7), 2504-2508.
[http://dx.doi.org/10.1128/JCM.40.7.2504-2508.2002] [PMID: 12089270]
[22]
Kasper, D.C.; Prusa, A.R.; Hayde, M.; Gerstl, N.; Pollak, A.; Herkner, K.R.; Reiter-Reisacher, R. Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. J. Clin. Microbiol., 2009, 47(1), 164-167.
[http://dx.doi.org/10.1128/JCM.01435-08] [PMID: 18987175]
[23]
Ashburn, D.; Evans, R.; Skinner, L.J.; Chatterton, J.M.; Joss, A.W.; Ho-Yen, D.O. Comparison of relative uses of commercial assays for Toxoplasma gondii IgM antibodies. J. Clin. Pathol., 1992, 45(6), 483-486.
[http://dx.doi.org/10.1136/jcp.45.6.483] [PMID: 1624595]
[24]
Van Enk, R.A.; James, K.K.; Thompson, K.D. Evaluation of three commercial enzyme immunoassays for toxoplasma and cytomegalovirus antibodies. Am. J. Clin. Pathol., 1991, 95(3), 428-434.
[http://dx.doi.org/10.1093/ajcp/95.3.428] [PMID: 1847580]
[25]
Verhofstede, C.; Van Renterghem, L.; Plum, J. Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii. J. Clin. Pathol., 1989, 42(12), 1285-1290.
[http://dx.doi.org/10.1136/jcp.42.12.1285] [PMID: 2613922]
[26]
Tanyuksel, M.; Guney, C.; Araz, E.; Saracli, M.A.; Doganci, L. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis. J. Microbiol., 2004, 42(3), 211-215.
[PMID: 15459650]
[27]
Candolfi, E.; Pastor, R.; Huber, R.; Filisetti, D.; Villard, O. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn. Microbiol. Infect. Dis., 2007, 58(1), 83-88.
[http://dx.doi.org/10.1016/j.diagmicrobio.2006.12.010] [PMID: 17368807]
[28]
Montoya, J.G.; Jordan, R.; Lingamneni, S.; Berry, G.J.; Remington, J.S. Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life. Clin. Infect. Dis., 1997, 24(4), 676-683.
[http://dx.doi.org/10.1093/clind/24.4.676] [PMID: 9145743]
[29]
Rayes, A.A.; Nobre, V.; Teixeira, D.M.; Serufo, J.C.; Filho, G.B.; Antunes, C.M.; Lambertucci, J.R. Tropical pyomyositis and human toxocariasis: a clinical and experimental study. Am. J. Med., 2000, 109(5), 422-425.
[http://dx.doi.org/10.1016/S0002-9343(00)00512-X] [PMID: 11020398]
[30]
Abe, K.; Shimokawa, H.; Kubota, T.; Nawa, Y.; Takeshita, A. Myocarditis associated with visceral larva migrans due to Toxocara canis. Intern. Med., 2002, 41(9), 706-708.
[http://dx.doi.org/10.2169/internalmedicine.41.706] [PMID: 12322796]
[31]
Bellanger, A-P.; Runge, M.; Wendling, D.; Humbert, P. Lumbar myositis associated with Toxocara spp. infection. Reumatol. Clin., 2014, 10(1), 54-55.
[http://dx.doi.org/10.1016/j.reuma.2013.04.008] [PMID: 24239450]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy